These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23223448)

  • 1. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
    Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
    J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
    Huang Q; Miller MR; Schappet J; Henry MD
    Cancer Biol Ther; 2015; 16(1):125-36. PubMed ID: 25455932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.
    Miller MR; Ma D; Schappet J; Breheny P; Mott SL; Bannick N; Askeland E; Brown J; Henry MD
    Mol Cancer; 2015 Jul; 14():141. PubMed ID: 26220087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
    Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
    Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.
    Shimojo H; Kobayashi M; Kamigaito T; Shimojo Y; Fukuda M; Nakayama J
    Prostate; 2011 Aug; 71(11):1151-7. PubMed ID: 21656825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.
    Inamori KI; Beedle AM; de Bernabé DB; Wright ME; Campbell KP
    Glycobiology; 2016 Dec; 26(12):1284-1296. PubMed ID: 27496765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.
    Palmieri V; Bozzi M; Signorino G; Papi M; De Spirito M; Brancaccio A; Maulucci G; Sciandra F
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2182-2191. PubMed ID: 28572004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fer kinase regulates cell migration through α-dystroglycan glycosylation.
    Yoneyama T; Angata K; Bao X; Courtneidge S; Chanda SK; Fukuda M
    Mol Biol Cell; 2012 Mar; 23(5):771-80. PubMed ID: 22238358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
    Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
    Balci-Hayta B; Talim B; Kale G; Dincer P
    BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2.
    Inamori K; Hara Y; Willer T; Anderson ME; Zhu Z; Yoshida-Moriguchi T; Campbell KP
    Glycobiology; 2013 Mar; 23(3):295-302. PubMed ID: 23125099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
    de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP
    J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico structural analysis of E509K mutation in LARGE and T192M mutation in Alpha Dystroglycan in the inhibition of glycosylation of Alpha Dystroglycan by LARGE.
    Bhattacharya S; Das A; Bagchi A
    Comput Biol Chem; 2016 Oct; 64():313-321. PubMed ID: 27565399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE.
    Fujimura K; Sawaki H; Sakai T; Hiruma T; Nakanishi N; Sato T; Ohkura T; Narimatsu H
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1162-71. PubMed ID: 15752776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis.
    Zhang HZ; Xia XY; Zhu F; Shen H; Song K; Shang ZJ
    J Oral Maxillofac Surg; 2014 Jun; 72(6):1106-18. PubMed ID: 24629698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.
    Yamamoto T; Kato Y; Shibata N; Sawada T; Osawa M; Kobayashi M
    Int J Exp Pathol; 2008 Oct; 89(5):332-41. PubMed ID: 18808525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.